Ubs Group Ag Nevro Corp Transaction History

Ubs Group Ag

$527 Billion
Q4 2024

A detailed history of Ubs Group Ag transactions in Nevro Corp stock. As of the latest transaction made, Ubs Group Ag holds 171,417 shares of NVRO stock, worth $982,219. This represents 0.0% of its overall portfolio holdings.

Number of Shares

171,417

Previous 9,581 1689.13%

Holding current value

$982,219

Previous $53,000 1101.89%

% of portfolio

0.0%

Previous 0.0%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$3.59 - $5.78 $580,991 - $935,412	161,836 Added 1689.13%	171,417 $637,000
Q3 2024 Nov 14, 2024	SELL	$4.71 - $10.1 $20,827 - $44,662	-4,422 Reduced 31.58%	9,581 $53,000
Q2 2024 Aug 13, 2024	SELL	$7.96 - $13.59 $199,047 - $339,831	-25,006 Reduced 64.1%	14,003 $117,000
Q1 2024 May 13, 2024	BUY	$13.56 - $20.78 $410,962 - $629,779	30,307 Added 348.28%	39,009 $563,000
Q4 2023 Feb 09, 2024	SELL	$14.18 - $22.31 $12.7 Million - $20 Million	-894,570 Reduced 99.04%	8,702 $187,000
Q3 2023 Nov 09, 2023	BUY	$18.22 - $25.85 $16.4 Million - $23.2 Million	898,629 Added 19354.49%	903,272 $17.4 Million
Q2 2023 Aug 11, 2023	SELL	$22.62 - $39.32 $74,872 - $130,149	-3,310 Reduced 41.62%	4,643 $118,000
Q1 2023 May 12, 2023	BUY	$30.17 - $41.11 $203,164 - $276,834	6,734 Added 552.42%	7,953 $287,000
Q4 2022 Feb 08, 2023	BUY	$36.43 - $49.4 $29,909 - $40,557	821 Added 206.28%	1,219 $48,000
Q3 2022 Nov 10, 2022	SELL	$40.66 - $53.03 $15,898 - $20,734	-391 Reduced 49.56%	398 $19,000
Q2 2022 Aug 10, 2022	BUY	$40.85 - $77.67 $4,779 - $9,087	117 Added 17.41%	789 $35,000
Q1 2022 May 16, 2022	SELL	$59.95 - $92.06 $1,858 - $2,853	-31 Reduced 4.41%	672 $48,000
Q4 2021 Feb 14, 2022	BUY	$81.07 - $121.29 $3,323 - $4,972	41 Added 6.19%	703 $57,000
Q3 2021 Nov 15, 2021	BUY	$101.99 - $166.36 $407 - $665	4 Added 0.61%	662 $77,000
Q2 2021 Aug 13, 2021	SELL	$141.6 - $179.06 $602,649 - $762,079	-4,256 Reduced 86.61%	658 $109,000
Q1 2021 May 12, 2021	BUY	$132.81 - $182.18 $150,075 - $205,863	1,130 Added 29.86%	4,914 $685,000
Q4 2020 Feb 11, 2021	BUY	$138.17 - $184.34 $204,491 - $272,823	1,480 Added 64.24%	3,784 $655,000
Q3 2020 Nov 12, 2020	BUY	$114.09 - $145.51 $204,221 - $260,462	1,790 Added 348.25%	2,304 $321,000
Q2 2020 Jul 31, 2020	SELL	$89.45 - $129.85 $23,257 - $33,761	-260 Reduced 33.59%	514 $61,000
Q1 2020 May 01, 2020	SELL	$70.23 - $144.31 $274,880 - $564,829	-3,914 Reduced 83.49%	774 $77,000
Q4 2019 Feb 14, 2020	SELL	$76.41 - $117.54 $137,614 - $211,689	-1,801 Reduced 27.75%	4,688 $551,000
Q3 2019 Nov 14, 2019	BUY	$61.52 - $91.1 $3,445 - $5,101	56 Added 0.87%	6,489 $558,000
Q2 2019 Aug 14, 2019	SELL	$58.04 - $66.99 $240,285 - $277,338	-4,140 Reduced 39.16%	6,433 $417,000
Q1 2019 May 14, 2019	BUY	$35.52 - $62.62 $225,232 - $397,073	6,341 Added 149.83%	10,573 $661,000
Q4 2018 Feb 14, 2019	SELL	$35.43 - $56.29 $25,828 - $41,035	-729 Reduced 14.69%	4,232 $164,000
Q3 2018 Nov 14, 2018	SELL	$44.22 - $75.47 $16,980 - $28,980	-384 Reduced 7.18%	4,961 $283,000
Q2 2018 Aug 14, 2018	SELL	$72.38 - $92.5 $9,698 - $12,395	-134 Reduced 2.45%	5,345 $427,000
Q1 2018 May 15, 2018	BUY	$69.46 - $88.57 $104,815 - $133,652	1,509 Added 38.01%	5,479 $474,000
Q4 2017 Feb 14, 2018	SELL	$65.94 - $93.31 $126,011 - $178,315	-1,911 Reduced 32.49%	3,970 $274,000
Q3 2017 Nov 14, 2017	SELL	$80.87 - $91.08 $2.7 Million - $3.04 Million	-33,373 Reduced 85.02%	5,881 $534,000
Q2 2017 Aug 14, 2017	BUY	N/A	17,409 Added 79.69%	39,254 $2.92 Million
Q1 2017 Nov 14, 2017	BUY	N/A	21,845	21,845 $2.05 Million

Others Institutions Holding NVRO

# of Institutions

145

Shares Held

37.6M

Call Options Held

622K

Put Options Held

1.39M

View Full List

About NEVRO CORP

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $203M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

More about NVRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account